Merck Capital Ventures


Home

About UsSubmit a Business PlanFAQsPortfolio CompaniesContact UsSite Map

Portfolio Companies

Merck Capital Ventures has made investments in the companies listed below.

For more information about these companies follow the link to their web site or go to their press release.

Acurian

AcurianAcurian Inc. provides pharmaceutical and biotechnology companies with the most comprehensive informatics base from which to launch a trial. Using Web-enabled and traditional tools, Acurian can strategically plan and implement recruitment, document exchange and site support to compress the clinical trial start-up phase.

Go to Acurian Home Page | View latest press releases for Acurian

 

Aegis Analytical Corporation

Aegis Analytical CorporationAegis Analytical Corporation is the leading provider of Manufacturing Informatics software systems for pharmaceutical, biotechnology, food, natural products, specialty chemical and medical device manufacturers. Customers use Aegis' Discoverant software system to dramatically improve the profitability, stability and regulatory compliance of their manufacturing processes.

Go to Aegis Analytical Home Page | View latest press releases for Aegis Analytical

 

Cytel

Cytel.Cytel Software Corporation provides statistical software and services for clinial trial simulation, design and analysis. The company provides expertise in applying advanced, validated statistical methods to optimize clinical trials for the Bio/Pharmaceutical industry.

Go to Cytel Home Page | View latest press releases for Cytel

 

High Throughput Genomics

HTG.
HTG provides qNPA technology and services for the life sciences industry, addressing current unmet needs and enabling a new era of drug discovery and diagnostics. The company's technology platform enables the accurate, sensitive, reproducible and repeatable measurement of molecular signatures through the multiplexed measurement of RNA expression levels, DNA and protein levels and function. qNPA data measure how drugs act and diseases are mediated at the level of whole cells, tissues, or organisms.

Go to HTG Home Page | View latest press releases for HTG

 

Nano Imaging Services

HTG.
NIS provides transmission electron microscopy (TEM) imaging services to the pharmaceutical, biotechnology and nanotechnology industries. The company has developed leading methodologies in cryo-TEM that delivers high resolution, three-dimensional images at the molecular level of specimens in their natural state. .

Go to NIS Corporation Home Page | View latest press releases for NIS

 

ImpactRx

ImpactRxFounded in October of 2000, the Impact Network is the source of an unprecedented intelligence capability for tracking the promotional initiatives of the pharmaceutical industry in real-time and measuring their effectiveness by linking this activity to the prescribing behavior of physicians. Based in Mount Laurel, New Jersey, ImpactRx is the nation’s first Promotion Research Organization (PRO) for the pharmaceutical industry. With a proprietary network currently comprised the nation’s highest-prescribing physicians, ImpactRx is the sole source of physician level data that directly links the impact of physician promotion on prescribing behavior. This new generation of market intelligence provides pharmaceutical companies with the decision support needed to make important strategic choices about the mix, timing and degree of promotional efforts.

Go to ImpactRx Home Page | View latest press releases for ImpactRx

 

MedCases

MedCasesMedCases is a medical education e-learning company and ACCME-accredited provider of continuing medical education (CME). We develop and execute high-quality, peer-reviewed clinical educational programs using interactive simulated patient encounters. MedCases uses a proprietary, Internet-based system to deliver comprehensive, cost-effective learning with applications for practicing physicians, pharmaceutical companies, academic medical centers, and health care delivery organizations

Go to MedCases Home Page | View latest press releases for MedCases

 

PHT Corporation

PHT CorporationPHT Corporation provides pharmaceutical companies, CROs, biotechnology firms, and medical device companies with web-based software, infrastructure, and services for the collection and processing of clinical trial data. PHT's Esendant™ Clinical Network is a Web-based, electronic data capture (EDC) and data management system that features a revolutionary open architecture design based on an XML platform.

Go to PHT Corporation Home Page | View latest press releases for PHT Corporation

 

VisEn Medical

VisEn MedicalVisEn Medical is a leading developer imaging technologies in real-time molecular mapping of disease states in vivo in research and drug development.  The Company's technology platforms were developed at the Massachusetts General Hospital's Center for Molecular Imaging Research and Harvard Medical School's.  The Company's FMT System and Optical Probe Portfolio provide quantifiable molecular imaging of disease progression and pharmaceutical activity in animals.

Go to VisEn Medical Home Page | View latest press releases for VisEn

 

 

| Home | About Us | Submit a Business Plan | FAQs | Portfolio Companies |
| Contact Us | Site Map |

© 2001 Merck Capital Ventures, L.L.C., 50 Tice Blvd. Woodcliff Lake, NJ 07677